Importantly, prostatic neoplasms were detected only in HFD Inpp4b−/− males, suggesting a modulatory role for INPP4B in obesity-induced prostatic neoplasms. Here, INPP4B is linked to obesity due to melanocortin 4 receptor deficiency.